This guideline has been developed to ensure that the processes used within the organisation when obtaining clinical samples are robust, reflect best practice, and comply with legislations.
The quality of clinical specimens and the method by which they are collected, stored, and transported can have a significant impact on ensuring an accurate diagnosis.
This guideline outlines the precautions required to prevent transmission of infection to staff and the wider community whilst obtaining, transporting, and handling specimens. These measures are required to ensure that high quality specimens are obtained for accurate diagnosis.
A specimen: Defined as any bodily substance taken from a person for the purpose of analysis, such as blood or urine. All specimens will be regarded as potentially infectious, and all those involved in collecting, handling and transporting specimens are to be trained in and follow infection control precautions to prevent transmission of infection.
The collection, storage and transportation of specimens are governed by legislations relating to both transportation and health and safety at work.
The following legislation applies:
Success in the laboratory is dependent on the correct collection packaging, storage, and transportation of specimens. Failing to follow this may result in sample rejection and therefore delay in clinical diagnosis and treatment.
Clinicians should ensure that:
The clinician taking specimens will ensure that the following principles are followed:
Colleagues involved with the obtaining of clinical samples, need to be conversant with the process of managing spillages of body fluid. NHS England » Chapter 1: Standard infection control precautions (SICPs)
Microbiological results are an important factor in prescribing appropriate antibiotic therapy. To ensure that accurate microscopy, culture and sensitivity results are obtained steps should be taken to avoid contamination of the specimen from the patient, clinician or the environment.
Samples for microbiological investigation will be sent to the laboratory as soon as a patient is considered to have an infection, and ideally prior to the use of antibiotics. Specimens taken during antibiotic therapy may produce misleading results. If antibiotics have been commenced details must be provided on the sample request form.
All samples should be obtained using an aseptic non-touch technique (ANTT procedure) .
Hazard Group 3 specimens from known or suspected high-risk infection, Table 1, should be clearly labelled as ‘danger of infection’. It is the clinician’s responsibility to ensure that tests that have been requested have the adequate clinical information documented on the request form and that ‘danger of infection’ is clearly labelled on the request forms and on the containers for all high-risk specimens.
Viral hepatitis | Typhoid Fever (Salmonella typhi/paratyphi) |
HIV infection | Anthrax |
Tuberculosis | Burkholderia pseudomallei |
Creutzfeldt-Jacob disease | Shigella dystenteriae |
Faecal samples from patients with E. coli O157 or Haemolytic uraemic syndrome | Faecal samples from patients with E. coli O157 or Haemolytic uraemic syndrome |
Hazard group 4 specimens, such as viral haemorrhagic fevers samples should not be sent and advice must be sought from the IPC Team and Consultant Microbiologist in consultation with UKHSA.
For accurate results to be obtained, specimens ideally should be received and processed by the laboratory as soon as possible.
However, where this is not possible, specimens should be stored within a designated sample only refrigerator for a maximum of 24 hours, at 4-8°C. This will help prevent bacteria and contaminants from multiplying and giving misleading results. The fridge temperature should be checked daily, and records kept for 2 years.
Blood cultures must not be refrigerated, and they must be transported to the laboratory without delay.
Under the Health and Safety at Work Act (1974), all staff have a responsibility to protect themselves and others e.g. the public, from any contamination from hazardous substances. All road transport of samples must be in accordance with current Carriage of Dangerous Goods by Road legislation.
Staff who carry/transport any clinical samples should ensure that samples are placed in a lidded, rigid, container that can be decontaminated.This is to prevent the risk of contamination in the event of spillage or leakage of the specimen. All transport containers should be decontaminated following each use.In the event of accidental spill, refer to NHS England » Chapter 1: Standard infection control precautions (SICPs).
Staff must only transport specimens in their vehicles in appropriate United Nations approved containers (UN3373). The UN3373 symbol shall be clearly visible on all external packaging (Department for Transport, March 2020).
Examples of transport containers:
For Nottinghamshire based services The Nottingham Blood Bikers will provide transport to convey samples to the laboratories out of hours (see appendix 8). For other areas follow locally agreed processes.
To reduce risks, the number of persons handling specimens will be kept to a minimum. It is also essential that staff follow the correct procedures to maximise the potential for accurate laboratory results.
Everyone involved in collecting, handling and transporting specimens should be educated about standard infection prevention and control precautions and be familiar with relevant guidelines NHS England » Chapter 1: Standard infection control precautions (SICPs).
Clinical staff are to ensure that all tests are fully explained to patients so that they are able to give fully informed consent, and this to be documented in the patient’s notes. If a person has been assessed and deemed to lack capacity, then the decision to obtain a sample should be made only if this is in their best interest and if this has been made in agreement with the multidisciplinary team. The procedure should be fully explained to ensure that the patient is informed as to what to expect or what they need to do e.g. when providing mid-stream urine sample, and this will then be documented within the Multi-Disciplinary Notes in line with the 01.06 Consent to Examination or Treatment and the 05.11 Deprivation Of Liberty Safeguards (Mental Capacity Act 2005).
There are to be clear local systems for informing patients of test results. At the time of the test, the patient will be advised of how long they will have to wait for the test result and the method by which they will be informed of it e.g. during their in-patient stay, a follow up appointment or by post. Isolation may be required while waiting for the results, dependent on the clinical manifestation.
When results are returned to a clinical area, there should be robust systems in place to ensure that results are:
Documented within the multidisciplinary notes and actioned appropriately.
The clinician that has requested or undertaken the test, or procedure, is responsible for accessing the results in a timely manner.
Health and Safety at Work etc. Act 1974, c.37. (Accessed: 11 April 2024).
Health and Safety Executive (no date) Personal protective equipment. (Accessed: 11 April 2024).
Department of Health and Social Care (2015) Health and Social Care Act 2008: code of practice on the prevention and control of infections. (Accessed: 11 April 2024).
The Management of Health and Safety at Work Regulations 1999 (SI 1999/3242). Accessed: 11 April 2024).
The Control of Substances Hazardous to Health Regulations 2002 (SI 2002/2677). (Accessed: 11 April 2024).
The Carriage of Dangerous Goods and Use of Transportable Pressure Equipment Regulations 2009 No.1348. (Accessed 14 June 2024).
NHS England (2022, updated 2024) National infection prevention and control manual (NIPCM) for England. (Accessed 21 June 2024).
Nottingham University Hospitals NHS Trust (2017) CL/CGP/084 Sample Collection and Blood Transfusion Requesting Procedure. (Accessed: 11 April 2024).
Shepherd, E. (2017) ‘Specimen collection 1: general principles and procedure for obtaining a midstream urine specimen’. Nursing Times, 113(7), pp. 45-47.
Shepherd, E. (2017) ‘Specimen collection 2: obtaining a catheter specimen of urine’. Nursing Times, 113(8), pp. 29-31.
Shepherd, E. (2017) ‘Specimen collection 3: faecal specimen from a patient with diarrhoea’. Nursing Times, 113(9), pp. 27-29.
Shepherd, E. (2017) ‘Specimen collection 4: procedure for obtaining a sputum specimen’. Nursing Times, 113(10), pp. 49-51
The Royal Marsden Manual of Clinical Nursing Procedures (2020) Chapter 13 Diagnostic Tests:Swab sampling: wound.
Check all equipment is within its expiry date
All samples should be transported to the Lab as soon as possible. If prompt transportation is not possible samples should be placed in a dedicated clinical sample fridge between 4-8 ° C and transported at the earliest opportunity.
Any samples for culture and sensitivity should ideally be sent before antibiotics are started.
Investigation |
Specimen |
Container |
Request form |
Faeces Clostridioides difficile |
Stool The sample must be type 5-7 on the Bristol Stool Chart. |
All three tests can be processed from the same sample. Ensure enough sample is provided. Fill to cover the spoon. |
GP samples - if C diff is suspected and the patient is <65 years the test must be specifically requested. Request form should detail any recent antibiotics and history of Clostridioides difficile. Formed stools, type 1-4 on the Bristol Stool Chart will be rejected. |
Faeces Routine Culture Food poisoning. Campylobacter, Salmonella, Shigella, E.coli 0157, Cryptosporidium |
Stool Minimum of 5ml (walnut sized) Do not mix with urine |
Culture and Sensitivity Request form should detail any foreign travel or suspected food poisoning outbreak |
|
Faeces Virology Norovirus, Rotavirus, Adenovirus |
Stool Minimum of 1ml |
Virology - Norovirus Norovirus testing is only performed if requested by infection control/microbiologist Formed stools, type 1-4 on the Bristol Stool Chart will be rejected. |
|
Urine |
|||
Urine Microscopy, culture and sensitivity Other test can be carried out on urine please refer to the local Pathology Handbook linked above for details on the container to be used. |
Red Top (Boric Acid) is preferable as our samples are transported to the lab. Ensure the sample reaches the fill line in the container (10ml). If the sample is less than 10ml use white top containers. |
|
On the request form clearly document if the sample is a Mid Stream Urine (MSU) or Catheter Specimen of Urine (CSU) The following samples will be considered unsuitable and will be rejected:
|
Swabs viral and bacterial |
|||
Culture and Sensitivity Wound Swab MRSA screen
|
Wound swabs should only be taken if clinically indicated or as part of a MRSA screen or other requested screening protocol. |
Detail any history of MRSA and recent antibiotics. Request MRSA screen or culture and sensitivity For dry areas, such as the anterior nares (nose) premoisten the swab with sterile water. If taking sputum as part of an MRSA screen please submit separately with a request form |
|
Other swab sites Throat Swab Eye swab Vesicles
|
Infections can be viral or bacterial in these sites. The swab medium will need to be selected for the suspected infection which will be bacterial or viral. |
Bacterial Staphylococcus aureus Group A Streptoccocus Viral Influenza, RSV, COVID-19 Herpes Simplex Virus Varicella Zoster
|
|
Sputum |
|||
Tuberculosis - mycobacterial infection |
Minimum of 1 ml of sputum
|
Ideally in the morning - Fresh, purulent sample on 3 consecutive days. |
|
Pneumonia MRSA screen Culture and sensitivity |
Minimum of 1 ml of sputum
|
Sputum samples that are predominantly saliva will be rejected Delays in arrival of the sample of more than 48hrs are undesirable |
A stool specimen should be collected at the earliest opportunity when patient exhibits type 5 to 7 on Bristol stool chart and an infectious cause suspected.
Please note that for microbiology and virology, formed stools, Bristol stool chart, Type 1-4 will not be tested.
NHS How To Take A Stool Sample (youtube.com)
A midstream specimen of urine is the best sample for culture and sensitivity where this can be achieved.
Urine can easily be contaminated during collection by bacteria, which colonise the perineum. If possible, the perineum should be cleaned with soap and water, front to back, prior to specimen collection to help reduce bacterial contamination.
Clinicians:
Please note that samples for other tests, such as legionella, will be rejected if sent in a red top container.
Urine samples for legionella testing will need to be placed in a white top container. Please refer to local guidelines for specific testing guidelines.
A specimen of urine from a catheterised patient will be obtained by aspiration from the self-sealing sampling port using Aseptic Non Touch Technique (ANTT).
The needle-free port should be cleaned with a wipe containing 2% Chlorhexidine and 70% isopropyl alcohol. Needles should never be used when obtaining catheter samples.
The catheter should never be disconnected to obtain a sample as this will break the closed system and serve as a portal of entry for micro-organisms.
The sample should never be collected from the urine bag.
Urine samples collected for culture should not be refrigerated for more than 24 hours.
Sputum samples will ideally be collected in the morning before eating, drinking and after brushing the teeth and rinsing well with water (do not use mouth wash). Brushing the teeth will reduce the risk of the sample being contaminated with debris or microbes present in the mouth.
If the sputum is thick and difficult to clear, administering nebuliser therapy may help to loosen the secretions. Alternatively, a physiotherapist may be able to assist.
Encourage the patient to take three deep breaths in through the nose and exhale through pursed lips (bring the lips tightly together so that they form a rounded hole shape), then force a cough.
Taking a wound swab is only recommended when clinical signs of infection are identified, and the information gained will affect treatment, or for screening purposes. Clinical signs of infection are:
As with all investigations any wound swab isolates should be reviewed alongside other clinical information and symptoms, and treatment will not be based on swab results alone.
If Fungal infection suspected ensure this is documented on the sample as won’t be routinely screened for.
If possible, it is best practice to take a swab before antibiotics are started.
Swab sampling: wound - Royal Marsden Manual (rmmonline.co.uk)
It is important that the specimen is supported with sound clinical information recorded on the microbiology request form. Details relating to the service user’s symptoms of infection, what type of wound it is and treatment history will assist the microbiologist in making an accurate diagnosis and appropriate recommendations for management.
Sensitivities for antibiotic treatment are not always returned with culture results because many isolates reflect bacterial colonisation, rather than infection. It may be necessary to obtain advice from the microbiologist to discuss the results and treatment of the case.
Requested by prescribing clinician, ensuring privacy and dignity, chaperone and consent are documented and considered.
Taking a throat swab is recommended to obtain samples of the mucous membrane. It may be used to identify a microorganism in a suspected infection or part of a screening programme to identify patients who may be carrying pathogens, such as Group A Strep, without displaying signs and symptoms.
Pathogens in the throat can be viral or bacterial so it essential the appropriate swab is selected for the suspected infection.
Examples of a Viral Swabs
An aseptic non touch technique (ANTT) is used to collect the sample to ensure that it is not contaminated from surrounding tissues or environment.
Out of Hours: Transportation of Samples - responsibilities
Out of hours (19:00 to 06:00 Monday to Friday, all day Saturday, Sunday and Bank Holidays)
The third layer has already been supplied to and is retained by NBB. It is a rigid container with the UN3373 diamond and description for compliant transport.
Version |
Date |
Expert writer |
Status (New, Edited) |
Comments and details of changes being made |
18.02 (Issue 1) |
May 2017 |
K Simpson on behalf of A Clarke |
|
Throat Swab and Blood Bikes added. Changes to Trust logo, name, formatting. EIA updated. |
18.02 (Issue 2) |
August 2017 |
A Clarke |
|
Amendments to EIA/section. |
18.02 (Issue 4) |
March 2021 |
B Amadi |
|
Addition and update of references. Addition of appendix 6. |
18.02 (Issue 4) |
April 2021 |
L West |
|
Reference number changed to 07.02. |
07.02 (Issue 4) |
July 2021 |
B Amadi |
|
Reference number changed to 07.02 in text. |
07.02 (Issue 4) |
July 2021 |
I Brackenridge |
|
Item 15.1 ‘Local Partnerships’ changed to ‘Community Health Services and Mental Health Services Division’. |
07.02 (Issue 5) |
June 2022 |
I Brackenridge/S Clarke |
|
Policy transferred to new Trust policy template. |
|
June 2024 |
Deborah Hamilton and IPC Team |
|
Edited and transferred to the new policy format for Infection Prevention and Control. |